364354-02-9

Basic information

• Product Name: 4-broMo-2-chloro-1-phenoxybenzene
• Synonyms: 4-broMo-2-chloro-1-phenoxybenzene
• CAS NO: 364354-02-9
• Molecular Formula: C12H8BrClO
• Molecular Weight: 283.54832
• EINECS: -0
• Mol File: 364354-02-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-broMo-2-chloro-1-phenoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-broMo-2-chloro-1-phenoxybenzene(364354-02-9)
• EPA Substance Registry System: 4-broMo-2-chloro-1-phenoxybenzene(364354-02-9)

Safety Data

• Hazardous Substances Data: 364354-02-9(Hazardous Substances Data)

Upstream product

• 3964-56-5 4-bromo-2-chlorophenol 
• 98-80-6 phenylboronic acid 
• 591-50-4 iodobenzene 

Relevant articles and documents

COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF

The present invention provides a novel compound that can improve the luminous efficiency, stability and life span of the element, an organic electronic element using the same, and an electronic device thereof.

COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF

The present invention relates to a compound for an organic electric element, the organic electric element using the same, and an electronic device thereof. According to the present invention, it is possible to achieve high luminous efficiency, low driving voltage, and high heat resistance of an element, and to improve the color purity and lifespan of the element. In one aspect, the present invention provides the compound represented by chemical formula 1.COPYRIGHT KIPO 2020

BRUTON'S TYROSINE KINASE INHIBITORS

Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):

Pyrrolopyrimidines as therapeutic agents

Chemical compounds having structural formula I and physiologically acceptable salts and metabolites thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases, whose activity is inhibited by these chemical compounds, are involved in immunologic, hyperproliferative, or angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyper proliferative disorders, rheumatiod arthritis, disorders of the immune system, trasplant refections and imflammatory disorders.